✦ LIBER ✦

SERUM SOLUBLE UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR (SUPAR) IS A USEFUL MARKER OF PROSTATE CANCER

✍ Scribed by Milanese, G.; Gasparri, L.; Dellabella, M.; Sidenius, N.; Galosi, A.B.; Minardi, D.; Blasi, F.; Fazioli, F.; Muzzonigro, G.

Book ID: 122727900
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 53 KB
Volume: 5
Category: Article
ISSN: 1569-9056
DOI: 10.1016/S1569-9056(06)61014-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble urokinase plasminogen activator

Soluble urokinase plasminogen activator receptor as a prognostic marker in men participating in prostate cancer screening

✍ A. Kjellman; O. Akre; O. Gustafsson; G. Høyer-Hansen; H. Lilja; U. Norming; T. P 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Increased Urokinase-Type Plasminogen Act

Increased Urokinase-Type Plasminogen Activator Receptor and Epidermal Growth Factor Receptor in Serum of Patients With Prostate Cancer

✍ Milanese, Giulio; Dellabella, Marco; Fazioli, Francesca; Pierpaoli, Elisa; Polit 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 246 KB

The receptor for urokinase-type plasmino

The receptor for urokinase-type plasminogen activator is a marker of activation in T-lymphocytes

✍ Møller, B.; Nykjær, A.; Gliemann, J.; Petersen, C.Munck 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Prognostic value of plasma soluble uroki

Prognostic value of plasma soluble urokinase plasminogen activator receptor (suPAR) in Danish patients with recurrent epithelial ovarian cancer (REOC)

✍ FARAH DIBA BEGUM; ESTRID V. S. HØGDALL; RIKKE RIISBRO; IB JARLE CHRISTENSEN; SVE 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Serum Soluble Urokinase-Type Plasminogen

Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children: A Single-Center Report

✍ Bock, M. E.; Price, H. E.; Gallon, L.; Langman, C. B. 📂 Article 📅 2013 🏛 American Society of Nephrology 🌐 English ⚖ 840 KB

Soluble urokinase plasminogen activator

Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy

✍ Ove Andersen; Jesper Eugen-Olsen; Kristian Kofoed; Johan Iversen; Steen B. Hauga 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB

## Abstract Circulating soluble urokinase plasminogen activator receptor (suPAR) reflects the immune and pro‐inflammatory status of the HIV‐infected patient. Highly active antiretroviral therapy (HAART) suppresses suPAR. Independent of the immune response to HAART, suPAR remains elevated in some HI